Asia’s #1 Conference for Biologics Supply Chain & Cold Chain Excellence

Christian Karol Saputra is a seasoned biopharmaceutical professional with over 12 years of experience in advancing drug development and biologics manufacturing. As the Head of Innovation Centre at PT Etana Biotechnologies Indonesia, he plays a pivotal role in overseeing technology transfer and process scale-up for critical biologics, including mRNA vaccines, monoclonal antibodies, erythropoietin, PCV subunit vaccines, and low molecular weight heparin (LMWH). His work also focuses on implementing advanced single-use systems to enhance production efficiency.

At the Etana Innovation Centre, Christian leads cross-functional initiatives that strengthen Indonesia’s biopharmaceutical capabilities. He collaborates closely with academic and funding institutions on strategic R&D programmes, including the development of a novel mRNA vaccine against dengue. Through his leadership, Christian continues to drive innovation and shape the future of biopharmaceutical manufacturing in Indonesia.

Mr. Christopher Ong is currently the Managing Director of DHL Express Singapore, a position he has held since November 2018. Responsible for driving sustainable growth in this key market, Chris has been focused on delivering great service quality to loyal customers through a highly motivated workforce. A strong advocate of corporate stewardship, Chris has also been invited to share his views publicly and at business forums on a variety of business topics including sustainability, SME strategies, trade and logistics, e-commerce, digitalization, people engagement and leadership.  

Chris joined DHL in 2006 and was responsible for Mergers and Acquisitions, Partnerships and Planning, First Choice (Six sigma) and GoGreen corporate programmes for Asia-Pacific. In October 2011, he was appointed Country Manager of DHL Express Vietnam before he took on the role of Managing Director for Malaysia and Brunei in March 2014. Prior to joining DHL, Chris worked at Temasek Holdings, where he was involved in transactions in the Transport, Logistics, Telecom, Media, Technology, and Manufacturing sectors. He graduated Summa Cum Laude with a Bachelor of Science in Mechanical Engineering from Tufts University, US.

Harry Murti is a seasoned scientist with over 17 years of experience in stem cell research and development. He currently serves as the Head of Manufacturing at PT. Bifarma Adiluhung (a subsidiary of PT. Kalbe Farma), where he oversees stem cell production.

Prior to this role, he was the Head of Stem Cell Research & Development at the Stem Cell and Cancer Institute (SCI-Kalbe). Harry earned his Ph.D. from IPB University, Indonesia, and completed postdoctoral research at Hanyang University, South Korea.

Notably, he played a pivotal role in securing the first Good Manufacturing Practice (GMP) certification from the Indonesian FDA in 2014 and obtaining the initial operational permit for stem cell processing from the Ministry of Health in 2013.

Customer-centric and pragmatic Supply Chain leader with over 15 years of experience spanning across supply chain operations and strategy, 3PL Management, S&OP, ERP implementation and Strategic Procurement. Currently taking on unique challenges of a noble cause organization as a Supply Chain Senior Manager at Hilleman Laboratories. Prior to this, I served over 10 years at Takeda Manufacturing Singapore in Procurement, Supply Planning and Logistics.

Nicolas is the newly appointed Head of Operations at PT. Kalbio Global Medika (KGM), Indonesia’s pioneer integrated biotechnology facility. Managing a complex scope that spans DS Mammalian Cell Culture, DP Aseptic Filling, and Site Engineering, Nicolas is at the forefront of the site’s 2026 transformation. His current mandate focuses on achieving world-class yield optimization and COGS efficiency, while strategically expanding KGM’s portfolio into Monoclonal Antibodies (mAbs) for oncology. He is a key advocate for building a resilient Indonesian biotech ecosystem through local talent development and supply chain sustainability

Dr. Phil Huang is a distinguished scientist and innovator in the field of cell therapy technologies, with over a decade of industry experience. He has held pivotal roles, including as a Postdoctoral Fellow at UCLA and Research Scientist at CytoLumina Technologies Corp., where he developed advanced non-invasive systems on a chip for rare cells capture. As Vice President of R&D at Precision Biotech Taiwan, Dr. Huang led groundbreaking projects, acquiring government fundings and completing Taiwan's first Phase I/IIa clinical trial for allogeneic immune cell therapy. Now serving as Technical and Global BD director at StemCyte International Ltd., he drives advancements in allogeneic cell therapies, cell material services, and innovative biotechnologies as well as global partnership.

Rosaline started her career with MSD in 2016, where she has built a solid foundation in the pharmaceutical industry since 2016. Leading the global transportation team within the Global Center of Excellence, she focuses on optimizing product movement while adhering to regulatory and business standards. Her role encompasses strategic logistics initiatives and budget management. Recently years, Rosaline has emphasized sustainability and digital transformation in logistics, implementing changes that lower environmental impact while boosting efficiency. With a strong background in trade compliance, she ensures adherence to international regulations.

Prior to joining MSD, Rosaline honed her skills at several third-party logistics companies, gaining expertise in international freight and customer relationship management. This diverse experience enables her to align 3PL processes with client needs, positioning her as a vital force in advancing logistics strategies in the pharmaceutical sector. She is committed to driving innovation and sustainability in logistics to benefit the healthcare industry.

Tony Lugg is the Chairperson of the Transported Asset Protection Association in Asia Pacific (TAPA APAC), a leading global association that brings together supply chain industry leaders and organizations to uphold the highest standards of supply chain resilience and sustainability. He also serves on the Board of Advisors for International Crisis Room 360 (ICR360) and is a Founding Member of the Supply Chain Innovation Network.

Previously, Tony was the Director of Logistics Purchasing and Centre of Excellence for Lear Corporation Asia Pacific, a leading Tier 1 global automotive manufacturer ranked #148 on the Fortune 500. In this role, he oversaw logistics for the Seating (JIT) and E-Systems Divisions across Asia Pacific, as well as global distribution, sequencing, and warehousing.

Mr. Vipul Doshi has been in pharmaceutical Industry from more than four decades with diverse leadership and operational expertise across development, manufacturing, R&D, GXP quality assurance (QA) and manufacturing operations (parenterals, solid dosage forms, biotechnology, transdermal, biologics and vaccines).

He has been leading the Quality and Regulatory affairs function in the Pharmaceutical Companies of high credentials. Throughout his career he has been providing passionate global leadership and pioneered in guiding the companies to meet the Global Regulatory, Quality Standards and Compliance requirements.

He has been a Great Contributor in developing and implementing Quality attributes and Culture of Excellence based upon a set of core values and ethical practices, which integrate and improve business operations and enhance the compliance within the Organization.

Raj has nearly 30 years of experience in law enforcement and regulatory roles, with expertise in criminal intelligence, anti-counterfeiting, and pharmaceutical crime. He previously served in Singapore’s Police Intelligence and Criminal Investigation Departments and later held key enforcement and prosecutorial responsibilities at the Health Sciences Authority.

Currently, as Regional Director at the Pharmaceutical Security Institute, Raj works to strengthen public-private collaboration across Asia Pacific and leads capacity-building initiatives for law enforcement agencies. He also lectures at the National University of Singapore and consults for the United Nations Office on Drugs and Crime on enforcement and legislative strategies.

Wilman Low is the Head of Global Account Management Life Sciences & Healthcare/Pharma Specialized Network APAC at DHL Supply Chain leading team of global account managers partnering strategic accounts in Life Sciences & Healthcare.  He also supports sector development and growth initiatives across the Asia Pacific region on Pharma Specialized Network. With more than a decade of deep specialisation in healthcare logistics in areas such as clinical trials, pharmaceuticals, cold chain, medical technology, warehousing, and major account management, Wilman brings a strong blend of operational expertise and strategic insight to the industry.

His extensive experience spans critical capabilities such as 3PL management, project management, cold chain operations, program management, and designing resilient, end‑to‑end supply chain solutions that meet stringent healthcare compliance standards. He is known for turning complex supply chain challenges into competitive advantages for global healthcare partners.

Wilman holds an MBA from the University of Birmingham and has long been recognized for his contributions to advancing Life Sciences & Healthcare supply chains in the region.

Clinical research professional with over 15 years of experience in clinical trial management (Phase I to IV), focusing on biologics, generics, and post-marketing surveillance. Proficient in quality assurance, compliance, and clinical research practices.

Biography - A leader with 20+ years of experience in aseptic manufacturing and quality excellence, inspiring innovation and continuous improvement in the pharmaceutical industry.

I bring over 20 years of experience in the biopharmaceutical and pharmaceutical industry, specializing in Quality functions, Commissioning & Qualification, and Formulation Development. My career has focused on aseptic manufacturing of bulk and final fill operations, where I have successfully led the setup of new facilities, managed regulatory audits, and driven technology transfers across diverse dosage forms. I am passionate about operational excellence, digital innovation, and continuous improvement—transforming complex challenges into opportunities for growth. Over the years, I have guided teams through critical projects that strengthened compliance, enhanced efficiency, and elevated standards in manufacturing.

As I share my journey, my goal is not only to highlight the importance of quality and innovation but also to inspire the next generation of professionals to embrace excellence, adaptability, and a forward-looking mindset in shaping the future of our industry.